TLSI
NASDAQ · Biotechnology
Trisalus Life Sciences Inc
$2.43
-0.09 (-3.57%)
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+78.2% upside
Low Target
$2.61
Average Target
$4.33
High Target
$5.56
Current Price
$2.43
Current
$2.43
$2.43
Target
$4.33
$4.33
$2.61
$4.33 avg
$5.56
Scenario Analysis
Bear Case
$2.61
7.4%
Low target
Base Case
$4.33
+78.2%
Avg target
Bull Case
$5.56
+128.8%
High target
Risk/Reward
17.4x
Highly favorable
Price in Context
52-Week High
$7.95
-69.4% from high
52-Week Low
$2.20
+10.5% from low
Target vs 52W High
$4.33
-45.5% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.7% |
| AMGN | Hold | 42 | 43% | $190.87 | -59.0% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +115.8% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -18.6% |
| REGN | Buy | 36 | 72% | $76.80 | -92.0% |
| MRNA | Hold | 31 | 32% | $149.45 | -33.1% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -55.2% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -33.8% |